GenEmbryomics Engages WallachBeth to Pursue Listing on a US National Stock Exchange MELBOURNE, Australia, July 19, 2023 (GLOBE NEWSWIRE) -- GenEmbryomics, a medical genetics company with world leading intellectual property, today announced that it has retained WallachBeth Capital...